Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) per Share - Schedule of Basic and Diluted Net Income (Loss) Per Share (Details)

v3.24.2.u1
Net Income (Loss) per Share - Schedule of Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Net income (loss) $ 3,462 $ (11,644) $ (66,754) $ (28,609) $ (8,182) $ (95,363)
Reallocation of net income attributable to participating securities (41)   0   0 0
Net income (loss) attributable to common stockholders - diluted 3,421   (66,754)   (8,182) (95,363)
Net income (loss) attributable to common stockholders - basic $ 3,421   $ (66,754)   $ (8,182) $ (95,363)
Denominator:            
Weighted average common shares outstanding - basic (in shares) 156,473,080   148,882,160   154,774,899 147,664,534
Weighted average effect of potentially dilutive securities:            
Effect of potentially dilutive stock warrants (in shares) 102,533   0   0 0
Total potentially dilutive securities 15,090,863   0   0 0
Weighted average common shares outstanding - diluted (in shares) 171,563,943   148,882,160   154,774,899 147,664,534
Net income (loss) per share attributable to common stockholders - basic (in dollars per share) $ 0.02   $ (0.45)   $ (0.05) $ (0.65)
Net income (loss) per share attributable to common stockholders - diluted (in dollars per share) $ 0.02   $ (0.45)   $ (0.05) $ (0.65)
Stock options            
Weighted average effect of potentially dilutive securities:            
Effect of potentially dilutive stock (in shares) 13,047,919   0   0 0
Restricted stock units            
Weighted average effect of potentially dilutive securities:            
Effect of potentially dilutive stock (in shares) 1,940,411   0   0 0